American Vietnamese Biotech (HSTC:AMV) Gross-Profit-to-Asset % : 0.00% (As of . 20)

View and export this data going back to 2009. Start your Free Trial

What is American Vietnamese Biotech Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. American Vietnamese Biotech's annualized Gross Profit for the quarter that ended in . 20 was ₫ Mil. American Vietnamese Biotech's average Total Assets over the quarter that ended in . 20 was ₫ 0 Mil. Therefore, American Vietnamese Biotech's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 was Not Available.

American Vietnamese Biotech Gross-Profit-to-Asset % Historical Data

The historical data trend for American Vietnamese Biotech's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Vietnamese Biotech Gross-Profit-to-Asset % Chart

American Vietnamese Biotech Annual Data

Trend

Gross-Profit-to-Asset %

American Vietnamese Biotech Quarterly Data

Gross-Profit-to-Asset %

Competitive Comparison of American Vietnamese Biotech's Gross-Profit-to-Asset %

For the Biotechnology subindustry, American Vietnamese Biotech's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

American Vietnamese Biotech's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Vietnamese Biotech's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where American Vietnamese Biotech's Gross-Profit-to-Asset % falls into.

American Vietnamese Biotech Gross-Profit-to-Asset % Calculation

American Vietnamese Biotech's annualized Gross-Profit-to-Asset % for the fiscal year that ended in . 20 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: . 20 )	/	( (Total Assets (A: . 20 )	+	Total Assets (A: . 20 ))	/ count )
	=		/	( (	+	)	/ )
	=		/
	=	%

American Vietnamese Biotech's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: . 20 )	/	( (Total Assets (Q: . 20 )	+	Total Assets (Q: . 20 ))	/ count )
	=		/	( (	+	)	/ )
	=		/
	=	%

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (. 20) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

American Vietnamese Biotech Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of American Vietnamese Biotech's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

American Vietnamese Biotech (HSTC:AMV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Vietnamese Biotech Inc (HSTC:AMV) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

20 Road 13, Block DC Song Da, Thu Duc Ward, Ho Chi Minh, VNM

Website

http://www.amvibiotech.com

American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments and chemicals; producing and trading vaccines and medical biological products; real estate business and financial investment.